Peter Sandel

565 Fifth Avenue
Suite 2900
New York, NY 10017

Peter represents pioneering pharmaceutical and biotechnology companies in all stages of patent litigation, including trials and appeals.

He has litigated complex patent disputes in a wide array of areas, including foundational antibody technology, transgenic animal models, pharmaceutical manufacturing, chromatography, DNA sequencing, novel treatments for life-threatening diseases, and biosimilar challenges under the BPCIA.  Peter has also litigated patents regarding internet technologies, semiconductors, and LEDs.

Peter received his J.D. from New York University.  He also received a Ph.D. in Immunology from the University of Pennsylvania and a B.S. in Biology and Philosophy from Reed College.